Clinically significant bacteria and viruses can persist on transducers and equipment.
Reducing infection transmission during ultrasound
A practical workflow for MFM physicians and ultrasound technologists.
Chukwuma Onyeije, MD · Maternal-Fetal Medicine
Every examination is an infection-control decision
Pathogens are microscopic. The safety system cannot depend on seeing contamination.
Correct classification, barriers, gel, cleaning, and processing reduce transmission risk.
safe workflow
Classify. Prepare. Process. Verify.
Classify the contact route
Noncritical, semicritical, or critical.
Select the full barrier bundle
Hand hygiene, gloves, cover, and gel.
Process at the required level
Clean first, then disinfect or sterilize.
Build a verifiable unit system
Train, document, store, audit, and improve.
The tissue the probe touches determines the processing level
Intact skin
Routine transabdominal ultrasound.
Mucosa or nonintact skin
Vaginal probes; abdominal probes used on nonintact skin.
Sterile tissue or vascular system
Intraoperative transducers and devices entering sterile sites.
One route map prevents most errors
Skin contact
Needle or catheter
Mucosa or operative field
Cleaning must happen before disinfection
Cleaning is not optional
Visible gel and other material must be removed. Then use water with detergent, an enzymatic product, or a compatible wipe according to manufacturer instructions.
A disinfectant cannot work through residual material.
External examinations still require a deliberate plan
Percutaneous procedures require sterile barriers and sterile gel
field
The bundle
Hand hygiene · sterile gloves · sterile transducer cover · sterile gel from a single-use packet · strict aseptic technique.
“Bacteriostatic” and “preservative” do not mean sterile. The package must specifically say sterile.
Internal probes require high-level disinfection after every patient
Low-level disinfection is insufficient
Pathogenic organisms can survive low-level processing of transvaginal transducers.
The cover is an added barrier
It does not change the need to clean and high-level disinfect between patients.
A cover reduces exposure. It does not replace reprocessing.
Leakage reported in older studies of some commercial probe covers.
Leakage across 10 commercial brands in a 2020 study of 500 covers.
For intravaginal or intrarectal use, choose a product documented as a viral barrier, not merely a generic cover.
Gel selection changes with the procedure
Noncritical external exam
Nonsterile gel is acceptable on intact skin. Multiuse containers may be used.
Semicritical internal use
Use sterile or bacteriostatic gel from single-use packets inside and outside the cover.
Critical or percutaneous use
Use only gel specifically labeled sterile, supplied in a single-use packet.
HPV efficacy matters when selecting a system
Match the exact product, concentration, time, temperature, and transducer compatibility. The active ingredient alone is not the complete protocol.
The OPA update is nuanced
Newer studies found approximately 4-log to 5-log HPV inactivation. SMFM now states that OPA can be considered for high-level disinfection of vaginal transducers.
Operational constraint
OPA is a volatile organic solvent. Use adequate ventilation to reduce respiratory, eye, and skin irritation. Do not use it in ultrasound rooms or other rooms occupied by patients.
limited activity
4-log reduction
up to 5-log
Process the handle, then protect the processed probe
Remove
Discard the cover without contaminating clean surfaces.
Clean
Remove gel and visible material from probe and handle.
Process
Disinfect the transducer and handle at the required level.
Dry / verify
Complete the manufacturer's cycle and handling instructions.
Protect
Store in a clean or sterile single-use sleeve; date it as good practice.
The handle is part of the contaminated device
High-level disinfection that stops at the probe face leaves a preventable gap.
Cycle logging can support traceability
Some automated systems include documentation software. SMFM notes that logging is good practice but not currently mandated by guidelines.
The transducer is not the only contaminated surface
optimal frequency
Evidence does not define one best interval for every surface. Each practice must specify what is cleaned, by whom, with what compatible product, and how often.
Do not improvise compatibility
Quaternary ammonium products may be suitable for much equipment, but check manufacturer documentation before use.
Hand hygiene and gloves are separate safeguards
| Contact route | Hand hygiene | Gloves | Key point |
|---|---|---|---|
| Intact skin | Before and after patient contact | Operator discretion | Clean + low-level disinfect the probe |
| Semicritical use | Before and after patient contact | Nonsterile gloves | Cover + required gel + high-level disinfection for internal use |
| Critical use | Before and after patient contact | Sterile gloves | Strict aseptic technique; sterile cover and gel |
Gloves are not 100% leak-proof
Hand hygiene remains mandatory whether gloves are used or not.
Make hygiene visible
Performing hand hygiene in the patient's view can reinforce trust and safety.
A safe unit is designed by leadership
the system
Assign accountable ownership
Designate oversight, but keep ultimate responsibility with practice leadership.
Provide space, time, and supplies
A protocol fails when the physical workflow makes compliance unrealistic.
Train and supervise
Teach the rationale, the product instructions, and the exact local process.
Document and audit
Monitor adherence, investigate failures, and close the feedback loop.
Protect the culture
Do not normalize shortcuts because no transmission event is visible.
Rapid scenarios: choose the complete bundle
Routine anatomy scan on intact abdominal skin
Transvaginal cervical length
Amniocentesis under external ultrasound guidance
Abdominal imaging over a draining surgical wound
A one-page unit protocol aligns the team
Before contact
- Classify the planned examination.
- Confirm patient latex allergy.
- Select gloves, cover, and gel.
- Verify supplies and processing capacity.
After contact
- Remove and discard single-use items.
- Remove gel and visible debris.
- Clean probe and handle.
- Apply the required processing level.
Before storage
- Complete cycle and drying steps.
- Inspect the device.
- Document when required.
- Package in a clean or sterile sleeve.
System controls
- Train and competency-check staff.
- Define environmental cleaning.
- Track recalls and product changes.
- Escalate deviations immediately.
The protocol should make the safe action the easy action.
Strong workflow consensus. Important implementation gaps.
What is clear
- All probes require cleaning and disinfection between patients.
- Internal probes require high-level disinfection.
- Percutaneous procedures require sterile single-use gel.
- Probe covers do not replace reprocessing.
What needs local resolution
- Nonintact-skin discrepancy between Table 1 and Figure 1.
- Optimal frequency for cleaning nonprobe equipment.
- Whether cycle logging should be mandatory locally.
- Product-specific HPV efficacy and compatibility.
What leaders should do
- Reconcile policy with infection prevention and current AIUM guidance.
- Follow exact manufacturer instructions for use.
- Audit the full workflow, not only the final wipe.
- Update the protocol when products or guidance change.